Status:
UNKNOWN
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
Lead Sponsor:
Beijing Ditan Hospital
Conditions:
Chronic Hepatitis C
Eligibility:
All Genders
20-70 years
Brief Summary
This study was a clinical observational cohort study of two-way, non-intervention long-term dynamic follow-up. Enrolled in the Department of Liver Diseases, Beijing Ditan Hospital, Capital Medical Uni...
Detailed Description
This study was a clinical observational cohort study of two-way, non-intervention long-term dynamic follow-up. Enrolled in the Department of Liver Diseases, Beijing Ditan Hospital, Capital Medical Uni...
Eligibility Criteria
Inclusion
- Chronic hepatitis C patients treated with interferon plus ribavirin (PR) antiviral therapy (PR treatment greater than or equal to 6 months) and/or direct antiviral drugs (DAAs)
Exclusion
- Co-infected with hepatitis B virus or human immunodeficiency virus
- Had an autoimmune disease, liver tumour, or severe cardiac disease.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04071353
Start Date
August 1 2019
End Date
August 1 2020
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
liver disease center, Beijing Ditan Hospital
Beijing, Beijing Municipality, China, 100015